α‐Glycerophosphocholine in the Mental Recovery of Cerebral Ischemic Attacks: An Italian Multicenter Clinical Trial
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The clinical efficacy and the tolerability of alpha-glycerophosphocholine (alpha-GPC), a drug able to provide high levels of choline for the nervous cells of the brain and to protect their cell walls, have been tested in a clinical open multicenter trial on 2044 patients suffering from recent stroke or transient ischemic attacks. alpha-GPC was administered after the attack at the daily dose of 1000 mg im for 28 days and orally at the dose of 400 mg tid during the following 5 months after the first phase. The evaluation of the efficacy on the psychic recovery was done by the Mathew Scale (MS) during the period of im drug administration, and using the Mini Mental State Test (MMST), the Crichton Rating Scale (CRS), and the Global Deterioration Scale (GDS) during the following period of oral administration. The MS mean increased 15.9 points in 28 days in a statistically significant way (p < 0.001) from 58.7 to 74.6. At the end of the 5 month oral administration, the CRS mean significantly decreased 4.3 points, from 20.2 to 15.9 (p < 0.001); the MMST mean significantly increased (p < 0.001) from 21 to 24.3 at the end of the trial, reaching the "normality" score at the 3rd month assessment. The GDS score at the end of the trial corresponded to "no cognitive decline" or "forgetfulness" in 71% of the patients. Adverse events were complained of by 44 patients (2.14%); in 14 (0.7%) the investigator preferred to discontinue therapy. The most frequent complaints were heartburn (0.7%), nausea-vomit (0.5%), insomnia-excitation (0.4%), and headache (0.2%). The trial confirms the therapeutic role of alpha-GPC on the cognitive recovery of patients with acute stroke or TIA, and the low percentage of adverse events confirms its excellent tolerability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
Cited by
Parnetti, L., Amenta, F., & Gallai, V. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00312-8 · Cited by 132
“Studies in acute cerebro ascular diseases The treatment protocol was identical in the three trials (Tomasina et al., 1991; Aguglia et al., 1993; Barbagallo Sangiorgi et al., 1994).”
MethodCholine supplements: An update
Kansakar, U., Trimarco, V., Mone, P., Varzideh, F., Lombardi, A., & Santulli, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1148166 · Cited by 103
Tamura, Y., Takata, K., Matsubara, K., & Kataoka, Y. (2021) · Nutrients · doi:10.3390/nu13062091 · Cited by 20
Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men
Kerksick, C. M. (2024) · Nutrients · doi:10.3390/nu16234240 · Cited by 8
Metadata
- Authors
- SANGIORGI, G. B., BARBAGALLO, M., GIORDANO, M., MELI, M., & PANZARASA, R.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 1994-06
- Volume
- 717
- Issue
- 1
- Pages
- 253-269
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2127882504
- Cited by
- 74
- References
- 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: α‐Glycerophosphocholine in the Mental Recovery of Cerebral Ischemic Attacks: An Italian Multicenter Clinical Trial. https://app.cochat.ai/papers/10.1111/j.1749-6632.1994.tb12095.x
- The paper
- SANGIORGI, G. B., BARBAGALLO, M., GIORDANO, M., MELI, M., & PANZARASA, R. (1994). α‐Glycerophosphocholine in the Mental Recovery of Cerebral Ischemic Attacks: An Italian Multicenter Clinical Trial. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1994.tb12095.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.